The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Flagged first, then by citations
1 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 901–1,000 of 1,036
Cho, N. R., Chang, Y. J., Lee, D. C., Kim, J. R., Ko, D. S., & Choi, J. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250972 · Cited by 38
Virtual reality for pain management in advanced heart failure: A randomized controlled study
Groninger, H., Stewart, D., Fisher, J. M., Tefera, E. A., Cowgill, J., & Mete, M. (2021) · Palliative Medicine · doi:10.1177/02692163211041273 · Cited by 41
Jani, M., Girard, N., Bates, D. W., Buckeridge, D. L., Sheppard, T., Li, Y., Iqbal, U., Vik, S., Weaver, C., Seidel, J. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003829 · Cited by 38
Luu, C. H., Nguyen, G., Le, T.-T., Nguyen, T.-M. N., Phan, V. H. G., Murugesan, M., Mathiyalagan, R., Jing, L., Janarthanan, G., Yang, D., et al. (2022) · Gels · doi:10.3390/gels8040246 · Cited by 39
Kroenke, K., Baye, F. M., Lourens, S. G., Evans, E., Weitlauf, S., McCalley, S., Porter, B. W., Matthias, M. S., & Bair, M. J. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05121-4 · Cited by 42
Ladapo, J. A., Larochelle, M. R., Chen, A., Villalon, M. M., Vassar, S., Huang, D. Y. C., & Mafi, J. N. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0544 · Cited by 38
Rogers, A. H., Bakhshaie, J., Lam, H., Langdon, K. J., Ditre, J. W., & Zvolensky, M. J. (2018) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2018.1436085 · Cited by 38
Non-medical use of prescription drugs and cultural orientation among college students in China
Tam, C. C., Benotsch, E. G., Wang, X., Lin, D., Du, H., & Chi, P. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.08.012 · Cited by 38
Zhang, Z., Wang, J., Ping, Z., Jin, X., Yang, J., Yan, W., Chu, Q., Pain Group of the Chinese Society of Anesthesiology, Zhao, Y., Feng, Y., et al. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00762-2 · Cited by 46
Animal Venom in Modern Medicine: A Review of Therapeutic Applications
Kim, E., Hwang, D. H., Prakash, R. L. M., Ravi, D. A., Lee, H., Heo, Y., Munawir, A., Seyedian, R., & Kang, C. (2025) · Toxins · doi:10.3390/toxins17080371 · Cited by 49
Aberrant Opioid Use and Urine Drug Testing in Outpatient Palliative Care
Arthur, J. A., Haider, A., Edwards, T., Waletich-Flemming, J. M., Reddy, S., Bruera, E. D., & Hui, D. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2015.0335 · Cited by 38
Medication Overuse in Chronic Pain
Hsu, E. (2017) · Current Pain and Headache Reports · doi:10.1007/s11916-017-0606-z · Cited by 39
Duvivier, H., Gustafson, S., Greutman, M., Jangchup, T., Harden, A. K., Reinhard, A., & Warshany, K. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.01.005 · Cited by 39
Nugent, S. M., Yarborough, B. J. H., Smith, N. X., Dobscha, S. K., Deyo, R. A., Green, C. A., & Morasco, B. J. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.11.001 · Cited by 38
Fritz, J. M., King, J. B., & McAdams-Marx, C. (2017) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000571 · Cited by 38
Gilliam, W. P., Craner, J. R., Cunningham, J. L., Evans, M. M., Luedtke, C. A., Morrison, E. J. P., Sperry, J. A., & Loukianova, L. L. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.02.010 · Cited by 40
Prescription Opioid Use Before and After Hip Arthroscopy: A Caution to Prescribers
Westermann, R. W., Mather, R. C. “., Bedard, N. A., Anthony, C. A., Glass, N. A., Lynch, T. S., & Duchman, K. R. (2019) · Arthroscopy The Journal of Arthroscopic and Related Surgery · doi:10.1016/j.arthro.2018.08.056 · Cited by 38
Opioid prescribing after childbirth: overprescribing and chronic use
Osmundson, S. S., Min, J. Y., & Grijalva, C. G. (2019) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000527 · Cited by 40
A Review of Postoperative Pain Management for Thyroid and Parathyroid Surgery
Uhlmann, R. A., Reinhart, H. A., Postevka, E., Snyder, S. M., & Arenas, M. A. R. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.03.050 · Cited by 37
Synthesizing the Strength of the Evidence of Complementary and Integrative Health Therapies for Pain
Giannitrapani, K. F., Holliday, J., Miake-Lye, I. M., Hempel, S., & Taylor, S. L. (2019) · Pain Medicine · doi:10.1093/pm/pnz068 · Cited by 40
Medical Use and Misuse of Prescription Opioids in the US Adult Population: 2016–2017
Griesler, P. C., Hu, M., Wall, M. M., & Kandel, D. B. (2019) · American Journal of Public Health · doi:10.2105/ajph.2019.305162 · Cited by 39
Associations Between Opioid Prescribing Patterns and Overdose Among Privately Insured Adolescents
Groenewald, C. B., Zhou, C., Palermo, T. M., & Cleve, W. V. (2019) · PEDIATRICS · doi:10.1542/peds.2018-4070 · Cited by 38
Meghani, S. H., Wool, J. R., Davis, J., Yeager, K. A., Mao, J. J. J., & Barg, F. K. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.10.029 · Cited by 38
Lee, D. S., Hann, J., Klaire, S. S., Nikoo, M., Negraeff, M., & Azar, P. (2019) · A&A Practice · doi:10.1213/xaa.0000000000001138 · Cited by 40
Gender based differences, pharmacogenetics and adverse events in chronic pain management
Planelles, B., Margarit, C., Inda, M., Ballester, P., Muriel, J., Barrachina, J., Ajo, R., Esteban, M. D., & Peiró, A. M. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0118-9 · Cited by 38
Karmali, R. N., Ray, G. T., Rubinstein, A. L., Sterling, S., Weisner, C. M., & Campbell, C. I. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.107923 · Cited by 38
Association of Opioid Use With Pain and Satisfaction After Dental Extraction
Nalliah, R. P., Sloss, K. R., Kenney, B. C., Bettag, S., Thomas, S., Dubois, K. M., Waljee, J. F., & Brummett, C. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0901 · Cited by 38
Häuser, W., Schubert, T., Vogelmann, T., Maier, C., Fitzcharles, M., & Tölle, T. R. (2020) · BMC Medicine · doi:10.1186/s12916-020-01644-4 · Cited by 38
Goudman, L., Smedt, A. D., Forget, P., & Moens, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113747 · Cited by 38
Grigoras, C. A., Karanika, S., Velmahos, E., Alevizakos, M., Flokas, M.-E., Kaspiris-Rousellis, C., Evaggelidis, I.-N., Artelaris, P., Siettos, C. I., & Mylonakis, E. (2018) · Drugs · doi:10.1007/s40265-017-0846-6 · Cited by 37
Lossio-Ventura, J. A., Song, W., Sainlaire, M., Dykes, P. C., & Hernandez‐Boussard, T. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104739 · Cited by 37
Bedene, A., Dahan, A., Rosendaal, F. R., & van Dorp, E. L. A. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2114898 · Cited by 38
An Integrated LSTM-HeteroRGNN Model for Interpretable Opioid Overdose Risk Prediction
Dong, X., Wong, R., Lyu, W., Abell-Hart, K., Deng, J., Liu, Y., Hajagos, J., Rosenthal, R. N., Chen, C., & Wang, F. (2022) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2022.102439 · Cited by 40
Behar, E., Rowe, C. L., Santos, G., Coffa, D. A., Turner, C., Santos, N. C., & Coffin, P. O. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3911-z · Cited by 39
Becker, W. C., Edmond, S. N., Cervone, D. J., Manhapra, A., Sellinger, J. J., Moore, B. A., & Edens, E. L. (2017) · Pain Medicine · doi:10.1093/pm/pnx041 · Cited by 46
CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications
Sauver, J. L. S., Olson, J. E., Roger, V. L., Nicholson, W. T., Black, J. L., Takahashi, P. Y., Caraballo, P. J., Bell, E. J., Jacobson, D. J., Larson, N. B., et al. (2017) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s136341 · Cited by 37
Chakravarthy, B., Somasundaram, S., Mogi, J., Burns, R. M., Hoonpongsimanont, W., Wiechmann, W. F., & Lotfipour, S. (2017) · Substance Abuse · doi:10.1080/08897077.2017.1375061 · Cited by 40
Purcell, N., Zamora, K. A., Tighe, J., Li, Y., Douraghi, M., & Seal, K. H. (2017) · Pain Medicine · doi:10.1093/pm/pnx254 · Cited by 39
Prescription and Usage Pattern of Opioids after Thyroid and Parathyroid Surgery
Long, S. M., Lumley, C. J., Zeymo, A., & Davidson, B. J. (2018) · Otolaryngology · doi:10.1177/0194599818779776 · Cited by 36
Peckham, A. M., Niculete, M. E., Steinberg, H. R., & Boggs, D. L. (2017) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000000668 · Cited by 37
Levy, N., & Mills, P. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.09.005 · Cited by 39
Pu, L., Moyle, W., Jones, C., & Todorovic, M. (2018) · Journal of Advanced Nursing · doi:10.1111/jan.13929 · Cited by 38
Opioid cessation and chronic pain: perspectives of former opioid users
Goesling, J., DeJonckheere, M. J., Pierce, J. M., Williams, D. A., Brummett, C. M., Hassett, A. L., & Clauw, D. J. (2019) · Pain · doi:10.1097/j.pain.0000000000001493 · Cited by 37
Patient Patterns and Perspectives on Using Opioid Regimens for Chronic Cancer Pain
Wright, E. M., El-Jawahri, A. R., Temel, J. S., Carr, A. L., Safren, S. A., Park, E. R., Pirl, W. F., Bruera, E. D., & Traeger, L. N. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.02.023 · Cited by 36
Potnuru, P., Dudaryk, R., Gebhard, R. E., Diez, C., Velazquez, O. C., Candiotti, K. A., & Epstein, R. H. (2019) · Surgery · doi:10.1016/j.surg.2019.04.022 · Cited by 37
Dima, R., Francio, V. T., Towery, C., & Davani, S. (2018) · PubMed · Cited by 37
Value-Based Care for Musculoskeletal Pain: Are Physical Therapists Ready to Deliver?
Lentz, T. A., Goode, A. P., Thigpen, C. A., & George, S. Z. (2019) · Physical Therapy · doi:10.1093/ptj/pzz171 · Cited by 38
Obesity and Incident Prescription Opioid Use in the U.S., 2000–2015
Stokes, A., Lundberg, D. J., Hempstead, K., Berry, K. M., Baker, J. F., & Preston, S. H. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.12.018 · Cited by 37
Ma, K., Jin, Y., Wang, L., Feng, Z.-Y., Song, T., Yang, X.-Q., Chen, F., Duan, B.-L., Huang, Y., Xie, G., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001957 · Cited by 37
Ghosh, P., Imbriani, P., Caputi, N., Natoli, S., Schirinzi, T., Lazzaro, G. D., Covington, L., Sparks, A. D., Salnikova, Y., Rukavina, K., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202088 · Cited by 37
Gray, B. M., Vandergrift, J. L., Weng, W., Lipner, R. S., & Barnett, M. L. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.15328 · Cited by 37
Racial/ethnic disparities in the availability of hospital based opioid use disorder treatment
Chang, J. E., Franz, B. A., Cronin, C. E., Lindenfeld, Z., Lai, A. Y., & Pagán, J. A. (2022) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2022.108719 · Cited by 37
Beaudoin, F. L., Gutman, R., Merchant, R. C., Clark, M. A., Swor, R. A., Jones, J. S., Lee, D. C., Peak, D. A., Domeier, R. M., Rathlev, N. K., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000756 · Cited by 38
Abbate, L. M., Jeffreys, A. S., Coffman, C. J., Schwartz, T. A., Arbeeva, L. S., Callahan, L. F., Negbenebor, N., Kohrt, W. M., Schwartz, R. S., Vina, E. R., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23466 · Cited by 37
Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016–2021
Larochelle, M. R., Jones, C. M., & Zhang, K. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109933 · Cited by 36
Limiting the Duration of Opioid Prescriptions
Bateman, B. T., & Choudhry, N. K. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.0544 · Cited by 36
Effect of opioid prescribing guidelines in primary care
Chen, J. H., Hom, J., Richman, I. B., Asch, S. M., Podchiyska, T., & Johansen, N. A. (2016) · Medicine · doi:10.1097/md.0000000000004760 · Cited by 37
Lovejoy, T. I., Morasco, B. J., Demidenko, M. I., Meath, T. H. A., Frank, J. W., & Dobscha, S. K. (2016) · Pain · doi:10.1097/j.pain.0000000000000796 · Cited by 39
Recent development in cell encapsulations and their therapeutic applications
Wang, J., Ding, Z., Zhang, F., & Ye, W.-B. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.04.103 · Cited by 37
Trends in Prescription Opioids Detected in Fatally Injured Drivers in 6 US States: 1995–2015
Chihuri, S. T., & Li, G. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303902 · Cited by 36
Fleming, J. N., Lai, J. C., Te, H. S., Said, A., Spengler, E. K., & Rogal, S. S. (2017) · Clinical Transplantation · doi:10.1111/ctr.13119 · Cited by 36
Comparação da analgesia pós‐operatória com uso de metadona versus morfina em cirurgia cardíaca
de Carvalho, A. C., Sebold, F. J. G., Calegari, P. M. G., de Oliveira, B. H., & Schuelter‐Trevisol, F. (2017) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2017.09.005 · Cited by 36
Larance, B., Dobbins, T., Peacock, A., Ali, R. L., Bruno, R., Lintzeris, N., Farrell, M., & Degenhardt, L. J. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30003-8 · Cited by 36
Utilization and effectiveness of multimodal discharge analgesia for postoperative pain management
Desai, K. R., Carroll, I. R., Asch, S. M., Seto, T., McDonald, K. M., Curtin, C. M., & Hernandez‐Boussard, T. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.03.029 · Cited by 36
The Imperative for Patient-Centered Clinical Decision Support
Marcial, L. H., Richardson, J. E., Lasater, B. M., Middleton, B., Osheroff, J. A., Kawamoto, K., Ancker, J. S., Leeuwen, D. V., Lomotan, E. A., Al-Showk, S., et al. (2018) · eGEMs (Generating Evidence & Methods to improve patient outcomes) · doi:10.5334/egems.259 · Cited by 35
The Intersection of Lifetime History of Traumatic Brain Injury and the Opioid Epidemic
Corrigan, J., & Adams, R. (2018) · Addictive Behaviours · doi:10.1016/j.addbeh.2018.10.030 · Cited by 30
Lemons, A., DeGroote, N. P., Pérez, A., Craw, J. A., Nyaku, M. A., Broz, D., Mattson, C. L., & Beer, L. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001889 · Cited by 36
Long‐Term Opioid Therapy in Older Cancer Survivors: A Retrospective Cohort Study
Shah, R., Chou, L., Kuo, Y., & Raji, M. A. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15945 · Cited by 35
Costello, R. E., David, T., & Jani, M. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.04.030 · Cited by 36
Cost-Effectiveness of Intranasal Naloxone Distribution to High-Risk Prescription Opioid Users
Acharya, M., Chopra, D., Hayes, C. J., Teeter, B. S., & Martin, B. C. (2020) · Value in Health · doi:10.1016/j.jval.2019.12.002 · Cited by 38
Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions
Dave, C. V., Patorno, E., Franklin, J. M., Huybrechts, K. F., Sarpatwari, A., Kesselheim, A. S., & Bateman, B. T. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05150-z · Cited by 36
Fowler, C. A., Ballistrea, L. M., Mazzone, K. E., Martin, A. M., Kaplan, H., Kip, K. E., Ralston, K., Murphy, J. L., & Winkler, S. L. (2019) · JMIR Formative Research · doi:10.2196/11266 · Cited by 36
Malte, C. A., Berger, D. B., Saxon, A. J., Hagedorn, H., Achtmeyer, C. E., Mariano, A. J., & Hawkins, E. J. (2017) · Medical Care · doi:10.1097/mlr.0000000000000861 · Cited by 37
Clarke, H. A., Manoo, V., Pearsall, E. A., Goel, A., Feinberg, A. E., Weinrib, A., Chiu, J. C., Shah, B., Ladak, S. S. J., Ward, S. E., et al. (2020) · Canadian Journal of Pain · doi:10.1080/24740527.2020.1724775 · Cited by 36
Smith, B. C., Vigotsky, A. D., Apkarian, A. V., & Schnitzer, T. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.0802 · Cited by 36
Implementation and enforcement of state opioid prescribing laws
Stone, E. M., Rutkow, L., Bicket, M. C., Barry, C. L., Alexander, G. C., & McGinty, E. E. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108107 · Cited by 39
Molecular Interaction Between Butorphanol and κ-Opioid Receptor
Ji, J., Lin, W., Vrudhula, A., Jin, X., Yeliseev, A., Grothusen, J. R., Bu, W., & Liu, R. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005017 · Cited by 36
Rich, R., Chou, R., Mariano, E. R., Dopp, A. L., Sullenger, R. D., & Burstin, H. R. (2020) · NAM Perspectives · doi:10.31478/202008c · Cited by 35
Self-citationGress, K. L., Charipova, K., Kaye, A. D., Viswanath, O., & Urits, I. (2020) · Oncology and Therapy · doi:10.1007/s40487-020-00128-y · Cited by 36
Hirsh, A. T., Anastas, T., Miller, M. M., Quinn, P. D., & Kroenke, K. (2020) · American Psychologist · doi:10.1037/amp0000636 · Cited by 40
Wertheimer, G., Mathieson, S., Maher, C. G., Lin, C. C., McLachlan, A. J., Buchbinder, R., Pearson, S., & Underwood, M. R. (2020) · Pain Medicine · doi:10.1093/pm/pnaa322 · Cited by 35
Isolation and Pharmacological Characterization of Six Opioidergic Picralima nitida Alkaloids
Creed, S. M., Gutridge, A. M., Argade, M. D., Hennessy, M. R., Friesen, J. B., Pauli, G. F., van Rijn, R. M., & Riley, A. P. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c01036 · Cited by 35
Szmulewicz, A., Bateman, B. T., Levin, R., & Huybrechts, K. F. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20071038 · Cited by 56
Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans
Babalonis, S. L., Lofwall, M. R., Sloan, P. A., Nuzzo, P. A., Fanucchi, L. C., & WALSH, S. L. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05293-1 · Cited by 36
Increasing Evidence for the Limited Role of Opioids to Treat Chronic Noncancer Pain.
Ashburn, M., & Fleisher, L. (2018) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2018.19327 · Cited by 30
Schepman, P. B., Thakkar, S., Robinson, R., Malhotra, D., Emir, B., & Beck, C. (2021) · Journal of Pain Research · doi:10.2147/jpr.s310368 · Cited by 35
Kosakowski, S., Benintendi, A., Lagisetty, P., Larochelle, M. R., Bohnert, A. S. B., & Bazzi, A. R. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07210-9 · Cited by 37
Hincapie‐Castillo, J. M., & Goodin, A. J. (2023) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5606 · Cited by 35
A comprehensive review on ziconotide
Lin, J., Chen, S.-W., Butt, U. D., Yan, M., & Wu, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31105 · Cited by 39
Tobin, D. G., Forte, K. K., & McGee, S. J. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.15172 · Cited by 35
Do racial/ethnic disparities exist in recommended migraine treatments in US ambulatory care?
Charleston, L. I., & Burke, J. F. (2017) · Cephalalgia · doi:10.1177/0333102417716933 · Cited by 35
Opioid Use in Chronic Pain Patients with Chronic Kidney Disease: A Systematic Review
Nagar, V. R., Birthi, P., Salles, S. S., & Sloan, P. A. (2016) · Pain Medicine · doi:10.1093/pm/pnw238 · Cited by 37
Characteristics of self-inflicted drug overdose deaths in North Carolina
Austin, A. E., Proescholdbell, S., Creppage, K. E., & Asbun, A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.09.014 · Cited by 36
Service Use Preceding Opioid-Related Fatality
Olfson, M., Wall, M. M., Wang, S., Crystal, S., & Blanco, C. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17070808 · Cited by 38
Toyé, F., Seers, K., Tierney, S., & Barker, K. L. (2017) · BMC Family Practice · doi:10.1186/s12875-017-0663-8 · Cited by 38
Managing non‐serious low back pain in the emergency department: Time for a change?
Machado, G. C., Rogan, E., & Maher, C. G. (2017) · Emergency Medicine Australasia · doi:10.1111/1742-6723.12903 · Cited by 36
The need for better access to pain treatment: learning from drug consumption trends in the USA
Scuteri, D. (2017) · Functional Neurology · doi:10.11138/fneur/2017.32.4.229 · Cited by 35
Psychiatric Aspects of Acute Porphyria: a Comprehensive Review
Duque, L., Patarroyo-Rodríguez, L., Gotlib, D., & Molano-Eslava, J. C. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0867-1 · Cited by 37
Mischel, R. A., Dewey, W. L., & Akbarali, H. I. (2018) · iScience · doi:10.1016/j.isci.2018.03.003 · Cited by 38
Postoperative surgical trainee opioid prescribing practices (POST OPP): an institutional study
Olsen, K. R., Hall, D. J., Mira, J. C., Underwood, P. W., Antony, A. B., Vasilopoulos, T., & Sarosi, G. A. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.03.011 · Cited by 35
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
